Divi's Laboratories Ltd.

NSE: DIVISLAB | BSE: 532488 | ISIN: INE361B01024 | Industry: Pharmaceuticals
| Expensive Performer

6355.00
-0.59%
Phillip Capital
Divi's Q1FY16 operating performance was just in line with our estimates with 26%/32% growth in sales/adjusted profit. Going ahead, the management expects to maintainsteadygrowthledbyprocessimprovementintheexistinggenericmolecules...
Divi's Laboratories Ltd. is trading above its 200 day SMA of 6304.5
More from Divi's Laboratories Ltd.
Recommended